Baxter International Inc. BAX
Set alert
As of Nov 3, 10:42 AM ET
- YTD
- +28.81%
- 1 year
- +35.17%
- Open
- 24.04
- Prev close
- 24.22
- Mkt cap
- 12.71B
- Vol
- 917.42K
- Avg vol
- 6.59M
- EPS
- -1.21
- P/E
- 0.00
- Div yield
- 0.17%
More statistics
- Low
- 23.92
- High
- 24.59
- Forward P/E
- 11.86
- Beta
- 0.67
- Short ratio
- 3.45
- Inst. own
- 109.51%
- Dividend
- 0.04
- Ex-div date
- Aug 27, 2026
- Earnings
- Feb 11, 2027
- 50-d avg
- 24.58
- 200-d avg
- 21.34
- 1y target
- 27.08
1Y chart
Events in this range
- Nov 28, 2025Dividend: 0.01
- Feb 12, 2026Earnings: 0.44; estimate 0.53; surprise -16.98%
- Feb 27, 2026Dividend: 0.01
- Apr 30, 2026Earnings: 0.36; estimate 0.311; surprise 15.76%
- May 29, 2026Dividend: 0.01
- Jul 30, 2026Earnings: 0.56; estimate 0.3665; surprise 52.8%
- Jul 31, 2026Rating: Wells Fargo · Equal-Weight → Equal-Weight
- Jul 31, 2026Rating: TD Cowen · Hold → Hold
- Aug 28, 2026Dividend: 0.01
- Oct 5, 2026Rating: Citigroup · Neutral → Neutral
- Oct 7, 2026Rating: Barclays · — → Underweight
- Oct 29, 2026Earnings: 0.58; estimate 0.518; surprise 11.97%
- Oct 30, 2026Rating: Wells Fargo · Equal-Weight → Equal-Weight
- Oct 30, 2026Rating: JP Morgan · Neutral → Neutral
Signals (49)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Nov 3, 2026 | 1 hour ago |
| SMA: Bearish | Oct 29, 2026 | 5 days ago |
| MACD: Sell Signal | Oct 29, 2026 | 5 days ago |
| SMA: Bullish | Oct 22, 2026 | 1 week ago |
| SMA: Bearish | Oct 20, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| MACD: Buy Signal | Sep 30, 2026 | 1 month ago |
| RSI: Oversold | Sep 18, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 14, 2026 | 2 months ago |
| RSI: Overbought | Jul 30, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 28, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 14, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 24, 2026 | 4 months ago |
| SMA: Bullish | Jun 18, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 18, 2026 | 4 months ago |
| SMA: Bearish | Jun 17, 2026 | 4 months ago |
| RSI: Overbought | Jun 12, 2026 | 4 months ago |
| SMA: Bullish | Jun 9, 2026 | 4 months ago |
| SMA: Bullish | May 18, 2026 | 5 months ago |
Newest 20 of 49.
Key statistics
- Market cap
- 12.53B
- Enterprise value
- 18.70B
- Trailing P/E
- 0.00
- Forward P/E
- 11.86
- PEG ratio
- 36.68
- Price / sales
- 1.08
- Price / book
- 1.93
- EPS (TTM)
- -1.21
- Beta
- 0.67
- Dividend yield
- 0.17%
- Payout ratio
- 154.67%
- Profit margin
- -6.23%
- Revenue (TTM)
- 11.61B
- Revenue growth
- 5.00%
- Free cash flow
- 1.22B
- Total cash
- 1.98B
- Total debt
- 8.81B
- Return on equity
- -9.04%
- Shares outstanding
- 517.35M
- Short % of float
- 7.24%
- 50-day average
- 24.58
- 200-day average
- 21.34
Analyst view
Consensus: hold
- Target (low)
- 20.00
- Target (mean)
- 27.08
- Target (high)
- 40.00
- Strong buy1
- Buy1
- Hold12
- Sell0
- Strong sell1
Next earnings
Feb 11, 2027
Expected Feb 11, 2027. Consensus EPS estimate 0.59583.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 11, 2027 | Dec 30, 2026 | 0.60 | — | — | — |
| Oct 29, 2026 | Sep 30, 2026 | 0.518 | 0.58 | +0.06 | +11.97% |
| Jul 30, 2026 | Jun 30, 2026 | 0.3665 | 0.56 | +0.19 | +52.80% |
| Apr 30, 2026 | Mar 31, 2026 | 0.311 | 0.36 | +0.05 | +15.76% |
| Feb 12, 2026 | Dec 31, 2025 | 0.53 | 0.44 | -0.09 | -16.98% |
| Oct 30, 2025 | Sep 30, 2025 | 0.60 | 0.69 | +0.09 | +15.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | JP Morgan | main | Neutral | Neutral |
| Oct 30, 2026 | Wells Fargo | main | Equal-Weight | Equal-Weight |
| Oct 7, 2026 | Barclays | init | — | Underweight |
| Oct 5, 2026 | Citigroup | main | Neutral | Neutral |
| Jul 31, 2026 | TD Cowen | main | Hold | Hold |
| Jul 31, 2026 | Wells Fargo | main | Equal-Weight | Equal-Weight |
About Baxter International Inc.
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- baxter.com
News
- International Assets Investment Management LLC Acquires 72,405 Shares of Baxter International Inc. $BAX
- JP Morgan Maintains Neutral on Baxter International, Lowers Price Target to $25
- Wells Fargo Maintains Equal-Weight on Baxter International, Raises Price Target to $25
- What Baxter International (BAX) Said on Its Q3 Earnings Call
- Baxter Q3 Earnings Beat on Broad-Based Growth, '26 Outlook Raised
- Baxter International Inc. (BAX) Q3 2026 Earnings Call Transcript
- Why Is Baxter Stock Trading Lower on Thursday?
- Why Is Baxter Stock Trading Lower on Thursday?
- Compared to Estimates, Baxter (BAX) Q3 Earnings: A Look at Key Metrics
- Baxter Intl Q3 2026 Earnings Call Transcript
Your note
Sign in to keep a note on BAX — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BORZI JAMES W | Officer | Stock Award(Grant) | Mar 5, 2025 | 73,134 |
| GRADE JOEL T. | Chief Financial Officer | Stock Award(Grant) | Feb 26, 2026 | 279,828 |
| HIDER ANDREW P | Chief Executive Officer | Stock Award(Grant) | Feb 26, 2026 | 572,239 |
| KNIGHT HEATHER | Chief Operating Officer | Stock Award(Grant) | Mar 5, 2025 | 177,362 |
| MASON JEANNE K | Officer | Stock Award(Grant) | Mar 5, 2025 | 199,659 |
| RASUL REAZUR | Officer | Stock Award(Grant) | Feb 8, 2026 | 139,846 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 15.82% | 81,842,105 | 1.98B | Jun 29, 2026 |
| Pzena Investment Management LLC | 12.07% | 62,425,636 | 1.51B | Sep 29, 2026 |
| Dodge & Cox Inc. | 11.29% | 58,386,345 | 1.41B | Jun 29, 2026 |
| FMR, LLC | 10.42% | 53,913,831 | 1.31B | Jun 29, 2026 |
| Vanguard Capital Management LLC | 6.52% | 33,754,280 | 817.69M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 4.65% | 24,057,190 | 582.78M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Dodge & Cox Funds-Dodge & Cox Stock Fund | 7.47% | 38,623,700 | 935.65M | Jun 29, 2026 |
| BLACKROCK EQUITY DIVIDEND FUND | 3.67% | 18,965,221 | 459.43M | Jul 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.17% | 16,397,162 | 397.22M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.59% | 13,382,913 | 324.20M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.29% | 11,833,128 | 286.66M | Jun 29, 2026 |
| VANGUARD WINDSOR FUNDS-Vanguard Windsor Fund | 2.02% | 10,439,598 | 252.90M | Jul 30, 2026 |